Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
FGFR3-targeted antibody-drug conjugate
DRUG CLASS:
FGFR3-targeted antibody-drug conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
LY3076226 (6)
AMB302 (4)
LY3076226 (6)
AMB302 (4)
›
Associations
(10)
News
Trials
VERI cancer hierarchy
Reset Filters
FGFR3 overexpression
Bladder Cancer
FGFR3 overexpression
Bladder Cancer
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
FGFR3 overexpression
Glioblastoma
FGFR3 overexpression
Glioblastoma
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
FGFR3-TACC3 fusion
Bladder Cancer
FGFR3-TACC3 fusion
Bladder Cancer
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
FGFR3-TACC3 fusion
Glioblastoma
FGFR3-TACC3 fusion
Glioblastoma
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
AMB302
Sensitive: D – Preclinical
AMB302
Sensitive
:
D
FGFR3-TACC3 fusion
Lung Cancer
FGFR3-TACC3 fusion
Lung Cancer
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
FGFR3-TACC3 fusion
Bladder Cancer
FGFR3-TACC3 fusion
Bladder Cancer
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
FGFR3-BAIAP2L1 fusion
Bladder Cancer
FGFR3-BAIAP2L1 fusion
Bladder Cancer
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
FGFR3 R248C
Bladder Cancer
FGFR3 R248C
Bladder Cancer
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
FGFR3 S249C
Bladder Cancer
FGFR3 S249C
Bladder Cancer
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
FGFR3 G370C
Bladder Cancer
FGFR3 G370C
Bladder Cancer
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
LY3076226
Sensitive: D – Preclinical
LY3076226
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login